Tag: Results
CannTrust to Hold Third Quarter 2018 Financial Results Conference Call

CannTrust to Hold Third Quarter 2018 Financial Results Conference Call

VAUGHAN, Ontario, Nov. 10, 2018 /PRNewswire/ -- CannTrust Holdings Inc. ("CannTrust" or the "Company") , one of Canada's leading and most trusted licensed producers of ...

Lees verder
Bradesco Results in the 3rd Quarter of 2018

Bradesco Results in the 3rd Quarter of 2018

SAO PAULO, Nov. 1, 2018 /PRNewswire/ -- The main figures obtained by Bradesco are presented below: 1. Recurring Net Income in the 3(rd) quarter recorded R$5.471 billion (an ...

Lees verder
Medasense Announces Positive Results From Clinical Outcome Studies Using the NOL® Monitoring Technology for Optimized Pain Control

Medasense Announces Positive Results From Clinical Outcome Studies Using the NOL® Monitoring Technology for Optimized Pain Control

RAMAT GAN, Israel, October 31, 2018 /PRNewswire/ -- The leading study, investigating NOL-guided opioid administration, demonstrated that using the NOL technology significantly ...

Lees verder
Landis+Gyr Announces First Half FY 2018 Financial Results

Landis+Gyr Announces First Half FY 2018 Financial Results

ZUG, Switzerland, Oct. 26, 2018 /PRNewswire/ -- Landis+Gyr (SWISS: LAND.SW) today announced financial results for the first half of fiscal year 2018 (April 1 - September 30, ...

Lees verder
Merck Presents Updated Results for Bifunctional Immunotherapy M7824 at ESMO 2018 Congress

Merck Presents Updated Results for Bifunctional Immunotherapy M7824 at ESMO 2018 Congress

DARMSTADT, Germany, October 22, 2018 /PRNewswire/ -- The information contained is not intended for distribution in the USA, Canada or the UK  ESMO Abstract # M7824 (TGF ...

Lees verder
Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile

Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile

TAIPEI, Taiwan, July 26, 2018 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announced today that it has successfully completed a Phase 1 multiple ...

Lees verder
Infosys (NYSE: INFY) Announces Results for the Quarter Ended June 30, 2018

Infosys (NYSE: INFY) Announces Results for the Quarter Ended June 30, 2018

BENGALURU, India, July 13, 2018 /PRNewswire/ -- - Digital revenues at $803 million (28.4% of total revenues), sequential growth of 8.0% and year-on-year ...

Lees verder
Results From Pivotal Phase 3 PROSPER Trial of XTANDI[TM] (enzalutamide) in Men With Non-Metastatic Castration-Resistant Prostate Cancer Published

Results From Pivotal Phase 3 PROSPER Trial of XTANDI[TM] (enzalutamide) in Men With Non-Metastatic Castration-Resistant Prostate Cancer Published

TOKYO, June 29, 2018 /PRNewswire/ -- Results show enzalutamide plus androgen deprivation therapy significantly reduced the risk of developing metastases or death by 71 ...

Lees verder
Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrating Superiority of Crysvita® (burosumab) Treatment to Oral Phosphate

Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrating Superiority of Crysvita® (burosumab) Treatment to Oral Phosphate

NOVATO, California, TOKYO and LONDON, May 17, 2018 /PRNewswire/ -- Substantial Healing of Rickets Observed in 72% of Patients Treated with Crysvita Compared to 6% of Patients ...

Lees verder
Pharming Group Interim Report on Financial Results for the First Quarter 2018

Pharming Group Interim Report on Financial Results for the First Quarter 2018

LEIDEN, Netherlands, May 17, 2018 /PRNewswire/ -- 93% increase in revenues from product sales and 110% increase in operating profit compared with the First Quarter 2017  ...

Lees verder
BizPress.nl